<DOC>
	<DOCNO>NCT00747227</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness new investigational modify light transmission monofocal intraocular lens compare conventional intraocular lens ( IOL ) .</brief_summary>
	<brief_title>Safety Efficacy Violet Visible Light Blocking Intraocular Lens ( IOL )</brief_title>
	<detailed_description>The investigational IOL find safe effective respect visual acuity , color vision , contrast sensitivity complication similar result ZA9003 control eye . Complication rate adverse event rate within FDA grid posterior chamber IOLs .</detailed_description>
	<mesh_term>Cataract</mesh_term>
	<criteria>Age 18 year age old Bilateral cataract phacoemulsification extraction posterior IOL implantation plan Visual potential eye 20/30 Snellen good cataract removal IOL implantation Preoperative corneal astigmatism 1.5 diopter less Use systemic ocular medication may affect vision Uncontrolled systemic recurrent ocular disease Requiring intraocular lens &lt; 15.0 &gt; 26.0 diopter Abnormal result FarnsworthMunsell D15 and/or Ishihara color plat History ocular trauma prior ocular surgery Known pathology may affect visual acuity visual field Corneal abnormalities Pupil abnormality Capsule zonular abnormality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>cataract</keyword>
	<keyword>monofocal</keyword>
	<keyword>intraocular lens</keyword>
	<keyword>acrylic</keyword>
</DOC>